Regenerative Medicine Provision Plan (Accepted by Japan’s MHLW)
The formal acceptance of a Regenerative Medicine Provision Plan serves as official verification that a clinical facility possesses the rigorous operational infrastructure, quality management systems, and safety protocols required to execute advanced cellular therapies appropriately. Only facilities that achieve this regulatory clearance are granted the statutory licenses necessary to administer regenerative treatments. Helene clinic strictly adheres to all statutory provisions mandated under Japan’s Ministry of Health, Labour, and Welfare (MHLW) regulatory frameworks. To date, we have successfully secured and maintained multiple official authorizations for our diverse regenerative medicine programs, ensuring the highest echelon of legal compliance and patient safety.
